Dana-Farber Cancer Institute · 6 hours ago
Scientist I
Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. They are seeking a research scientist to join the Tissue Biomarker Laboratory, focusing on spatial biology studies to analyze the tumor-immune microenvironment in immunotherapy patients.
CommunitiesHealth CareHealth DiagnosticsHospitalNon ProfitOncology
Responsibilities
Initiating and managing research projects
Overseeing data collection and analysis
Working with the Principal Scientist and Faculty Director to prepare manuscripts and research proposals
Collaborative studies involving extensive interactions with histopathology staff, research technicians, biomedical researchers, pathologists, clinicians, bioinformaticians, and data scientists
Qualification
Required
PhD in a biomedical-related discipline, such as immunology, biomedical engineering, and/or cancer biology
Experience in quantitative microscopy or computational data analysis
Initiating and managing research projects
Overseeing data collection and analysis
Working with the Principal Scientist and Faculty Director to prepare manuscripts and research proposals
Collaborative studies involving extensive interactions with histopathology staff, research technicians, biomedical researchers, pathologists, clinicians, bioinformaticians, and data scientists
Preferred
Experience working with teams and managing technicians
Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
H1B Sponsorship
Dana-Farber Cancer Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (191)
2024 (145)
2023 (155)
2022 (139)
2021 (105)
2020 (113)
Funding
Current Stage
Late StageTotal Funding
$88.08MKey Investors
Elaine and Eduardo Saverin FoundationThe DeGregorio Family FoundationLlama
2025-11-24Grant· $20M
2025-05-06Grant· $1M
2024-09-24Grant· $0.5M
Recent News
2026-01-25
GlobeNewswire
2026-01-22
Company data provided by crunchbase